Altogether our results are consistent with metformin exerting a potentially cardioprotective anti-inflammatory effect in patients with CVD, suppressing both age and metabolic inflammatory stress markers, independently of effects on BMI, insulin sensitivity, and without the onset of frank DM. This evidence concerns the gene INS and diabetes mellitus.